Inpatient Drug Treatment – Inpatient drug treatment is one of the two options available for those battling drug addiction. The other option is outpatient drug treatment. Both options c…
Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplement to the Biologics License Application (sBLA) supporting the use of ADCETRIS (brentuximab vedotin) for … 2012 for … Read more on Fort Mills Times
Research and Markets: Masitinib (Multiple Sclerosis) – Forecast and Market …
Filed under:drug rehab treatment options
GlobalData has released its new PharmaPoint Drug Evaluation report, Masitinib (Multiple Sclerosis) – Forecast and Market Analysis to 2022. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by … Read more on Fort Mills Times